Filippos Stavropoulos, Elena Georgiou, Natasa Schiza, Shaughn Bell, Robert H. Baloh, Kleopas A. Kleopa, Irene Sargiannidou
{"title":"Mitofusin 1过表达可在体外修复Mitofusin 2 K357T突变引起的线粒体动力学异常","authors":"Filippos Stavropoulos, Elena Georgiou, Natasa Schiza, Shaughn Bell, Robert H. Baloh, Kleopas A. Kleopa, Irene Sargiannidou","doi":"10.1111/jns.12564","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and aims</h3>\n \n <p>Mitofusin 1 (MFN1) and MFN2 are outer mitochondrial membrane fusogenic proteins regulating mitochondrial network morphology. <i>MFN2</i> mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects, which in the case of a GTPase domain mutant, were rescued following wild-type <i>MFN1/2</i> (<i>MFN1/2</i><sup><i>WT</i></sup>) overexpression. In this study, we compared the therapeutic efficiency between <i>MFN1</i><sup><i>WT</i></sup> and <i>MFN2</i><sup><i>WT</i></sup> overexpression in correcting mitochondrial defects induced by the novel <i>MFN2</i><sup><i>K357T</i></sup> mutation located in the highly conserved R3 region.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Constructs expressing either <i>MFN2</i><sup><i>K357T</i></sup>, <i>MFN2</i><sup><i>WT</i></sup>, or <i>MFN1</i><sup><i>WT</i></sup> under the ubiquitous chicken <i>β</i>-actin hybrid (<i>CBh</i>) promoter were generated. Flag or myc tag was used for their detection. Differentiated SH-SY5Y cells were single transfected with <i>MFN1</i><sup><i>WT</i></sup>, <i>MFN2</i><sup><i>WT</i></sup>, or <i>MFN2</i><sup><i>K357T</i></sup>, as well as double transfected with <i>MFN2</i><sup><i>K357T</i></sup>/<i>MFN2</i><sup><i>WT</i></sup> or <i>MFN2</i><sup><i>K357T</i></sup>/<i>MFN1</i><sup><i>WT</i></sup>.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>SH-SY5Y cells transfected with <i>MFN2</i><sup><i>K357T</i></sup> exhibited severe perinuclear mitochondrial clustering with axon-like processes devoid of mitochondria. Single transfection with <i>MFN1</i><sup><i>WT</i></sup> resulted in a more interconnected mitochondrial network than transfection with <i>MFN2</i><sup><i>WT</i></sup>, accompanied by mitochondrial clusters. Double transfection of <i>MFN2</i><sup><i>K357T</i></sup> with either <i>MFN1</i><sup><i>WT</i></sup> or <i>MFN2</i><sup><i>WT</i></sup> resolved the mutant-induced mitochondrial clusters and led to detectable mitochondria throughout the axon-like processes. <i>MFN1</i><sup><i>WT</i></sup> showed higher efficacy than <i>MFN2</i><sup><i>WT</i></sup> in rescuing these defects.</p>\n </section>\n \n <section>\n \n <h3> Interpretation</h3>\n \n <p>These results further demonstrate the higher potential of <i>MFN1</i><sup><i>WT</i></sup> over <i>MFN2</i><sup><i>WT</i></sup> overexpression to rescue CMT2A-induced mitochondrial network abnormalities due to mutations outside the GTPase domain. This higher phenotypic rescue conferred by <i>MFN1</i><sup><i>WT</i></sup>, possibly due to its higher mitochondrial fusogenic ability, may be applied to different CMT2A cases regardless of the <i>MFN2</i> mutation type.</p>\n </section>\n </div>","PeriodicalId":17451,"journal":{"name":"Journal of the Peripheral Nervous System","volume":null,"pages":null},"PeriodicalIF":3.9000,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jns.12564","citationCount":"0","resultStr":"{\"title\":\"Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro\",\"authors\":\"Filippos Stavropoulos, Elena Georgiou, Natasa Schiza, Shaughn Bell, Robert H. Baloh, Kleopas A. Kleopa, Irene Sargiannidou\",\"doi\":\"10.1111/jns.12564\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background and aims</h3>\\n \\n <p>Mitofusin 1 (MFN1) and MFN2 are outer mitochondrial membrane fusogenic proteins regulating mitochondrial network morphology. <i>MFN2</i> mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects, which in the case of a GTPase domain mutant, were rescued following wild-type <i>MFN1/2</i> (<i>MFN1/2</i><sup><i>WT</i></sup>) overexpression. In this study, we compared the therapeutic efficiency between <i>MFN1</i><sup><i>WT</i></sup> and <i>MFN2</i><sup><i>WT</i></sup> overexpression in correcting mitochondrial defects induced by the novel <i>MFN2</i><sup><i>K357T</i></sup> mutation located in the highly conserved R3 region.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Constructs expressing either <i>MFN2</i><sup><i>K357T</i></sup>, <i>MFN2</i><sup><i>WT</i></sup>, or <i>MFN1</i><sup><i>WT</i></sup> under the ubiquitous chicken <i>β</i>-actin hybrid (<i>CBh</i>) promoter were generated. Flag or myc tag was used for their detection. Differentiated SH-SY5Y cells were single transfected with <i>MFN1</i><sup><i>WT</i></sup>, <i>MFN2</i><sup><i>WT</i></sup>, or <i>MFN2</i><sup><i>K357T</i></sup>, as well as double transfected with <i>MFN2</i><sup><i>K357T</i></sup>/<i>MFN2</i><sup><i>WT</i></sup> or <i>MFN2</i><sup><i>K357T</i></sup>/<i>MFN1</i><sup><i>WT</i></sup>.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>SH-SY5Y cells transfected with <i>MFN2</i><sup><i>K357T</i></sup> exhibited severe perinuclear mitochondrial clustering with axon-like processes devoid of mitochondria. Single transfection with <i>MFN1</i><sup><i>WT</i></sup> resulted in a more interconnected mitochondrial network than transfection with <i>MFN2</i><sup><i>WT</i></sup>, accompanied by mitochondrial clusters. Double transfection of <i>MFN2</i><sup><i>K357T</i></sup> with either <i>MFN1</i><sup><i>WT</i></sup> or <i>MFN2</i><sup><i>WT</i></sup> resolved the mutant-induced mitochondrial clusters and led to detectable mitochondria throughout the axon-like processes. <i>MFN1</i><sup><i>WT</i></sup> showed higher efficacy than <i>MFN2</i><sup><i>WT</i></sup> in rescuing these defects.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Interpretation</h3>\\n \\n <p>These results further demonstrate the higher potential of <i>MFN1</i><sup><i>WT</i></sup> over <i>MFN2</i><sup><i>WT</i></sup> overexpression to rescue CMT2A-induced mitochondrial network abnormalities due to mutations outside the GTPase domain. This higher phenotypic rescue conferred by <i>MFN1</i><sup><i>WT</i></sup>, possibly due to its higher mitochondrial fusogenic ability, may be applied to different CMT2A cases regardless of the <i>MFN2</i> mutation type.</p>\\n </section>\\n </div>\",\"PeriodicalId\":17451,\"journal\":{\"name\":\"Journal of the Peripheral Nervous System\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2023-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jns.12564\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Peripheral Nervous System\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jns.12564\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Peripheral Nervous System","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jns.12564","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro
Background and aims
Mitofusin 1 (MFN1) and MFN2 are outer mitochondrial membrane fusogenic proteins regulating mitochondrial network morphology. MFN2 mutations cause Charcot-Marie-Tooth type 2A (CMT2A), an axonal neuropathy characterized by mitochondrial fusion defects, which in the case of a GTPase domain mutant, were rescued following wild-type MFN1/2 (MFN1/2WT) overexpression. In this study, we compared the therapeutic efficiency between MFN1WT and MFN2WT overexpression in correcting mitochondrial defects induced by the novel MFN2K357T mutation located in the highly conserved R3 region.
Methods
Constructs expressing either MFN2K357T, MFN2WT, or MFN1WT under the ubiquitous chicken β-actin hybrid (CBh) promoter were generated. Flag or myc tag was used for their detection. Differentiated SH-SY5Y cells were single transfected with MFN1WT, MFN2WT, or MFN2K357T, as well as double transfected with MFN2K357T/MFN2WT or MFN2K357T/MFN1WT.
Results
SH-SY5Y cells transfected with MFN2K357T exhibited severe perinuclear mitochondrial clustering with axon-like processes devoid of mitochondria. Single transfection with MFN1WT resulted in a more interconnected mitochondrial network than transfection with MFN2WT, accompanied by mitochondrial clusters. Double transfection of MFN2K357T with either MFN1WT or MFN2WT resolved the mutant-induced mitochondrial clusters and led to detectable mitochondria throughout the axon-like processes. MFN1WT showed higher efficacy than MFN2WT in rescuing these defects.
Interpretation
These results further demonstrate the higher potential of MFN1WT over MFN2WT overexpression to rescue CMT2A-induced mitochondrial network abnormalities due to mutations outside the GTPase domain. This higher phenotypic rescue conferred by MFN1WT, possibly due to its higher mitochondrial fusogenic ability, may be applied to different CMT2A cases regardless of the MFN2 mutation type.
期刊介绍:
The Journal of the Peripheral Nervous System is the official journal of the Peripheral Nerve Society. Founded in 1996, it is the scientific journal of choice for clinicians, clinical scientists and basic neuroscientists interested in all aspects of biology and clinical research of peripheral nervous system disorders.
The Journal of the Peripheral Nervous System is a peer-reviewed journal that publishes high quality articles on cell and molecular biology, genomics, neuropathic pain, clinical research, trials, and unique case reports on inherited and acquired peripheral neuropathies.
Original articles are organized according to the topic in one of four specific areas: Mechanisms of Disease, Genetics, Clinical Research, and Clinical Trials.
The journal also publishes regular review papers on hot topics and Special Issues on basic, clinical, or assembled research in the field of peripheral nervous system disorders. Authors interested in contributing a review-type article or a Special Issue should contact the Editorial Office to discuss the scope of the proposed article with the Editor-in-Chief.